The same team then demonstrated that integrin α5β1 binds ANGPTL2 in adipocytes, endothelial cells, and cancer cells because the effects of recombinant ANGPTL2 protein were blocked by integrin α5β1-neutralizing antibodies [5, 26, 63]. The gene discussed is ANGPTL2; the disease is cancer.